APA (7th ed.) Citation

A, K., T, L., D, G., DJL, J., RG, B., JD, P., . . . MP, G. (2024). Design, preparation and biological evaluation of new Rociletinib-inspired analogs as irreversible EGFR inhibitors to treat non-small-cell-lung cancer. Bioorganic & medicinal chemistry, 113, 117906. https://doi.org/10.1016/j.bmc.2024.117906

Chicago Style (17th ed.) Citation

A, Konsue, Lamtha T, Gleeson D, Jones DJL, Britton RG, Pickering JD, Choowongkomon K, and Gleeson MP. "Design, Preparation and Biological Evaluation of New Rociletinib-inspired Analogs as Irreversible EGFR Inhibitors to Treat Non-small-cell-lung Cancer." Bioorganic & Medicinal Chemistry 113 (2024): 117906. https://doi.org/10.1016/j.bmc.2024.117906.

MLA (9th ed.) Citation

A, Konsue, et al. "Design, Preparation and Biological Evaluation of New Rociletinib-inspired Analogs as Irreversible EGFR Inhibitors to Treat Non-small-cell-lung Cancer." Bioorganic & Medicinal Chemistry, vol. 113, 2024, p. 117906, https://doi.org/10.1016/j.bmc.2024.117906.